Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.57 USD | +1.58% | +7.53% | -9.51% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 134M 97.64M 7.83B |
---|---|---|---|---|---|
Net income 2024 * | -37M -27.05M -2.17B | Net income 2025 * | -47M -34.36M -2.76B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.62
x | P/E ratio 2025 * |
-3.1
x | Employees | 19 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.96% |
Latest transcript on DiaMedica Therapeutics Inc.
1 day | +1.58% | ||
1 week | +7.53% | ||
Current month | -7.22% | ||
1 month | -3.02% | ||
3 months | -3.75% | ||
6 months | +19.53% | ||
Current year | -9.51% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Pauls
CEO | Chief Executive Officer | 52 | 31/03/05 |
Scott Kellen
DFI | Director of Finance/CFO | 59 | 31/03/18 |
Ambarish Shah
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Kuntz
BRD | Director/Board Member | 66 | 29/05/23 |
Tanya Lewis
BRD | Director/Board Member | 53 | 28/02/23 |
James Parsons
BRD | Director/Board Member | 58 | 19/10/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 2.57 | +1.58% | 7,764 |
25/04/24 | 2.53 | +3.27% | 7,052 |
24/04/24 | 2.45 | +1.24% | 8,474 |
23/04/24 | 2.42 | -3.59% | 5,238 |
22/04/24 | 2.51 | +5.02% | 21,158 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.51% | 97.55M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- DMAC Stock